Advanced Neuromodulation Systems, Inc.

Cyberonics acknowledges purchase of $3.5M shares, shows no interest in merger

Published in Lab Business Week, September 26th, 2004

Cyberonics, Inc., (CYBX) announced that it was notified by the president and CEO of Advanced Neuromodulation Systems, Inc., (ANSI) that ANSI had purchased approximately 3.5 million shares or 14.8% of Cyberonics' common stock on the open market.

"ANSI's actions are evidence that yet another knowledgeable device market leader, in this case with highly relevant FDA [U.S. Food and Drug Administration] experience, has recognized the value of Cyberonics' VNS [vagus nerve stimulation] Therapy franchise, intellectual property, demand creation organization and model, profitable epilepsy business, and depression and other new indications opportunities," commented Robert P....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2004-09-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry